News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
FDA Approves Purdue Pharma L.P.'s New Opioid-Based Pain Medicine
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The U.S. Food and Drug Administration on Friday approved a new Purdue Pharma L.P. opioid-based drug that aims to provide "around-the-clock" relief to patients with moderate to severe pain.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
FDA
Drug pricing watchdog calls for increased transparency into FDA’s accelerated approval decisions
April 16, 2026
·
4 min read
·
Heather McKenzie
FDA
FDA mulls compounding for peptides previously flagged over safety risks
April 16, 2026
·
1 min read
·
Nick Paul Taylor
diabetes
Lilly’s Foundayo posts ‘outstanding’ diabetes data, possibly easing FDA safety concerns
April 16, 2026
·
2 min read
·
Gabrielle Masson
Drug Development
Whitepaper: CDMOs at a Crossroads
April 15, 2026
·
1 min read
·
BioSpace Insights